Marlys Koschinsky retweeted
Great to work with @MarlysLPA on #lipoprotein(a). While awaiting full results of #HORIZON important to remember we can act NOW with info on Lp(a) @BCMHeart @BCM_CVRI @nationallipid @CMHC_CME @Texas_Heart @society_eas @vijay_nambi @LaylaAbushamat
In honor of #CholesterolMonth, the NLA is proud to release the second installment of the Lipids Simplified Series: Lipoprotein(a) Management Simplified.
Following the success of our LDL-C Management Simplified publication, we felt there was no more timely or necessary topic to tackle next than Lp(a).
Authored by leading Lp(a) experts Marlys L. Koschinsky, PhD, FNLA and Christie M. Ballantyne, MD, MNLA, this article and accompanying infographic are designed to distill the complexity surrounding Lp(a) into clear, actionable guidance for clinicians. Our goal is simple: make this essential science more accessible and easier to apply in everyday practice.
🔗 Access the full article and infographic at lipid.org/resource/lipoprote….
👉 You can find this and other NLA articles under the Articles section of our newly launched lipid.org.
Stay tuned... more topics in the Lipids Simplified Series are on the way!
#LipoproteinA #Lpa #ASCVD #CardiovascularPrevention
@CBallantyneMD @MarlysLPA
Marlys Koschinsky retweeted
Proud of all our @nationallipid #LipidScholars and particularly our @NorthwellHealth CV fellow @RahulRege2 & LSP graduate @dipikagopal Great work from all! @Dr_Zahid_Ahmad Dr. Bart Duell, Dr. Anne Goldberg
Enjoyed presenting a unique case of cerebrotendinous xanthomatosis (CTX) at the Lipid Scholars Case Presentation! Thank you to the amazing faculty for their discussions 🤩 Had a great time at the NLA Clinical Update! @Dr_Zahid_Ahmad @dipikagopal @nationallipid @EugeniaGianos
Marlys Koschinsky retweeted
Marlys Koschinsky retweeted
Replying to @CJCJournals
Great to see this in print. A resource for physicians who ask: “how do I manage my patients with high Lp(a)”? Many thanks to the many experts who contributed. @iuliaiatan @LiamBrunham @ArsenaultBenoit @MarlysLPA @BaineyKevin @ShamirMehta and others!
Marlys Koschinsky retweeted
Replying to @UCSDCardiology
@UCSDCardiology @PamTaubMD @hsbhatia @MarlysLPA @EugeniaGianos @carolkirkpat3 @ArchnaBajajMD @CBallantyneMD @DrMichaelShapir @tmodarressi @FamilyHeartFdn @foundationofnla
What is Lp(a)?💡
Who better to explain than @dan_soffer, joined by @AKulkarniMD, @MWilkinsonMD, and @lipiddoc.
This Lipid Insights episode is your go-to refresher on all things Lp(a). Plus, you can earn CME/CE after you listen!🎧
Tune in on your favorite podcast platform and claim credit at lipid.org/lipidinsights.
Marlys Koschinsky retweeted
Celebrate LDL-C Awareness Day tomorrow by joining The Lipid Panel!
This month’s webinar, “LDL: Is It Really That Simple?” will walk through the NLA’s LDL-C management guidelines & real-world case studies.
✅ Stay current on the latest in lipidology
✅ Gain practical insights for your practice
🔗 Register now: lipid.org/thelipidpanel
#CholesterolMonth @LipidCNS @MWilkinsonMD @frankq1368
Marlys Koschinsky retweeted
We're excited to announce that an updated NLA statement on FH screening, diagnosis, & management in children & adult patients is in the works!
Our team is hard at work & can't wait to share our latest research & insights. Stay tuned. 🔜
#KnowFH #CholesterolMonth
Marlys Koschinsky retweeted
Amazing news for pediatric HoFH patients: Evkeeza® (evinacumab-dgnb), an ANGPTL3 antibody, has been FDA-approved for children as young as 1 year old.
Read the press release: investor.regeneron.com/news-…
#KnowHoFH #CholesterolMonth
Marlys Koschinsky retweeted
Congratulations to the team @Regeneron on this important milestone! Such great news for the HoFH community!!
#KnowHoFH
@FamilyHeartFdn @nationallipid @ASPCardio @AmerAcadPeds @AllisonJamison2 @KAWilemon @SethJBaumMD @DrMarthaGulati @FamilyHeartCMO @lipiddoc @CBallantyneMD
#BreakingNews: The U.S. FDA approved our medicine to treat children aged one to less than five years with #HoFH, an ultra-rare inherited condition that results in extremely high levels of LDL-C.
Learn more: bit.ly/3IHu3Mg
Marlys Koschinsky retweeted
NAD metabolism regulates proliferation of macrophages in atherosclerosis
ahajrnls.org/4mtv7Br
Marlys Koschinsky retweeted
Happy 39th 😉🎂to ACC Prevention Section leader @EugeniaGianos from your amigos at @CiccaroneCenter
Marlys Koschinsky retweeted
Happy birthday to the amazing @EugeniaGianos l Wishing you a fabulous birthday weekend and a year filled with joy, love and laughter.🎂💐🎉❤️
Marlys Koschinsky retweeted
Let's discuss Lp(a). Jump in and be part of this vital conversation. #CholesterolMonth
Questions are in the thread.👇
#Lpa #Lipidology #TwitterChat #Thread
Marlys Koschinsky retweeted
Replying to @nationallipid
One key fact that everyone should know about Lp(a):
Comprehensive cardiometabolic screening and management using just lipids and basic biometrics is incomplete without also considering a one-time Lp(a) value for the individual.
Lp(a) + lipoproteins + IR + glycemic status + noninvasive imaging results + inflammation + biometrics + clinical history
Marlys Koschinsky retweeted
Yes Lp(a) concentrations varies by race and ethnicity. First graphic below shows gender and racial differences in US. Also note there can be slight variability in coincentrations over time - women should repeat after menopause
Replying to @nationallipid
3️⃣Do elevated Lp(a) levels pose the same level of risk in different ethnic groups?
Marlys Koschinsky retweeted
Great to catch up with the great #CVPrev community at #ESCCongress2025 Incredible meeting bringing the world together to improve cardiovascular care. @ACCinTouch @rblument1 @RonBlankstein @DrEugeneYang @escardio @lenoxhill @NorthwellHealth @drstaceyrosen
Marlys Koschinsky retweeted
Replying to @MarlysLPA
@MarlysLPA and @MBBoffa review the emerging data on the role of Lp(a) in PAD: many mysteries remain, especially the mechanisms!
ahajrnls.org/40Yh7Yw








































